Welcome & Introduction

Biomarker - based Targeted therapy for Colorectal Cancer

No Name

Novel Targeted agents in Gastric Cancer

PancreaticCancer Newertratement Options

Novel Agents and Targets in HCC

Update on Management of Advanced Biliary Tract cancer

Management of Metastic Hormon Prostate Cancer

Selection of RX for RCC-Adjuvant &1st Line Rx in Metastatic disease

2nd Line options in Renal Cell Cancer

First-Line Immunotherapy in the management of RCC

Panel Discussion - Metastatic RCC

Current Treatment Landscape in first-line Urothelial Cancer

Overall survival at its core The New ABC Avelumab in Bladder Cancer

Panel Discussion- Management of Advance Bladder Cancer

Advances in Novel Formulation of Taxanes

Panel discussion - Management of Prostate cancer

Closing Remarks

Biomarker - based Targeted therapy for Colorectal Cancer

Novel Targeted agents in Gastric Cancer

PancreaticCancer Newertratement Options

Novel Agents and Targets in HCC

Update on Management of Advanced Biliary Tract cancer

Management of Metastic Hormon Prostate Cancer

Selection of RX for RCC-Adjuvant &1st Line Rx in Metastatic disease

2nd Line options in Renal Cell Cancer

First-Line Immunotherapy in the management of RCC

Panel Discussion - Metastatic RCC

Current Treatment Landscape in first-line Urothelial Cancer

Overall survival at its core The New ABC Avelumab in Bladder Cancer

Panel Discussion- Management of Advance Bladder Cancer

Advances in Novel Formulation of Taxanes

Panel discussion - Management of Prostate cancer